
Luban Therapeutics Private Limited
About Luban Therapeutics Private Limited
Data last updated:
Luban Therapeutics Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 01 October 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2015PTC268878. Its GSTIN is 27AACCL9323J1ZA (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sandeep Harijan Siddhu and Radhika Shrikrishna Shetye.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Shop No – D – 132 Jay – Vijay Nagari Ph – 1 Near Riddhi – Vinayak Hospital Nalasopara (W), Thane, Maharashtra, India – 401203.
As per the financials filed for FY 2023, the company reported a revenue of ₹2.65 Lakh, a decline of 19% compared to the previous year. For the same year it recorded a net loss of ₹1.22 Lakh (net margin -45.9%) and EBITDA of -₹1.22 Lakh (EBITDA margin -45.9%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 24% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Luban Therapeutics Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No – D – 132 Jay – Vijay Nagari Ph – 1 Near Riddhi – Vinayak Hospital Nalasopara (W), Thane, Maharashtra, India – 401203
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Luban Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Luban Therapeutics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Luban Therapeutics Private Limited, buy the company report.
Financials of Luban Therapeutics Private Limited
FY 2023 filings availableLuban Therapeutics Private Limited reported revenue of ₹2.65 Lakh (down 19% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 19% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 24%. EBITDA fell 341% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.22 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.22 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -45.9% | ||||
| Net Profit Margin | -45.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Luban Therapeutics Private Limited, buy the company report.
Board of directors of Luban Therapeutics Private Limited
Luban Therapeutics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Harijan Siddhu | Additional Director | 18 Sep 2018 | 8 Years 2 Months | Current |
| Radhika Shrikrishna Shetye | Additional Director | 11 Dec 2018 | 7 Years 11 Months | Current |
Peer comparison
Luban Therapeutics Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mankam Business Associates Private Limited | ₹2.66 Lakh (FY 2025) | -95.0% | Mandi, Himachal Pradesh, India | |||
| Ratotech Exim Private Limited | ₹2.66 Lakh (FY 2018) | Thane, Maharashtra, India | ||||
| Abt Motors Limited | ₹2.66 Lakh (FY 2024) | -93.0% | Coimbatore, Tamil Nadu, India | |||
| Diamond Fiscal Services Private Limited | ₹2.66 Lakh (FY 2024) | 2.0% | Nagpur, Maharashtra, India | |||
| Burnoor Organic Agriculture Farmers Producer Company Limited | ₹2.65 Lakh (FY 2025) | -97.0% | Asifabad, Telangana, India | |||
| Luban Therapeutics Private Limitedthis company | ₹2.65 Lakh (FY 2023) | -₹1.22 Lakh | -45.9% | -19.0% | Thane, Maharashtra, India | |
| Agua Organics Private Limited | ₹2.65 Lakh (FY 2025) | 4905.0% | Delhi, India | |||
| Ragja Impex Private Limited | ₹2.65 Lakh (FY 2018) | Tiruppur, Tamil Nadu, India | ||||
| H. A. Salt Private Limited | ₹2.65 Lakh (FY 2025) | -7.0% | Gandhidham, Gujarat, India | |||
| Daimound Food and Beverage Private Limited | ₹2.65 Lakh (FY 2021) | Kolkata, West Bengal, India | ||||
| Entise Glass Concepts Private Limited | ₹2.65 Lakh (FY 2022) | Pune, Maharashtra, India |
To see the full peer comparison of Luban Therapeutics Private Limited, buy the company report.
Shareholding
The shareholding of Luban Therapeutics Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Luban Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Luban Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Luban Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Luban Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCL9323J1ZA | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Luban Therapeutics Private Limited, buy the company report.
Recent activity
Luban Therapeutics Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Amit Ganesh Tripathi ceased to be Director on 01 Feb 2024.
Frequently asked questions
Luban Therapeutics is an active private limited company based in Thane, Maharashtra, India. The company works in other wholesale, within the trading industry. It was incorporated on 01 October 2015 (11+ years old) and is registered under CIN U74999MH2015PTC268878.
Luban Therapeutics has 2 current directors:
- Sandeep Harijan Siddhu - Additional Director
- Radhika Shrikrishna Shetye - Additional Director
The latest financial statements of Luban Therapeutics on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Luban Therapeutics is 27AACCL9323J1ZA, registered in Maharashtra.
The CIN (Corporate Identification Number) of Luban Therapeutics is U74999MH2015PTC268878. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Luban Therapeutics was incorporated on 01 October 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Luban Therapeutics by revenue are Mankam Business Associates Private Limited, Ratotech Exim Private Limited, Abt Motors Limited, Diamond Fiscal Services Private Limited, Burnoor Organic Agriculture Farmers Producer Company Limited and 5 more, all in the same principal business activity (wholesale trading).
Amit Ganesh Tripathi ceased to be Director on 01 Feb 2024. Devendra Yogendra Mishra ceased to be Director on 15 Jan 2019. Radhika Shrikrishna Shetye was appointed as Additional Director on 11 Dec 2018. Luban Therapeutics has 4 board changes on record in total.
The registered office of Luban Therapeutics is at Shop No – D – 132 Jay – Vijay Nagari Ph – 1 Near Riddhi – Vinayak Hospital Nalasopara W, Thane, Maharashtra, India – 401203.
Luban Therapeutics operates in the trading industry, in the other wholesale segment.
The compliance status of Luban Therapeutics is compliant as of 14 July 2026. The company is actively filing with the Registrar of Companies.

